A/H5N1 inactivated, split-virion influenza virus

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameA/H5N1 inactivated, split-virion influenza virus
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Inactivated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOrthomyxoviridae InfectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Pasteur
Active IndicationsN/A
Inactive IndicationsOrthomyxoviridae InfectionsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A